An investigation was announced concerning possible securities laws violations by Homology Medicines, Inc. and in connection with certain financial statements. Investors who purchased shares of Homology Medicines, Inc. (NASDAQ: FIXX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.comInvestigation announced for Investors in shares of Homology Medicines, Inc. (NASDAQ: FIXX) | openPR.com - New Public Relations: Business, Economy, Finances, Banking & Insurance
An investigation was announced concerning possible securities laws violations by Homology Medicines, Inc. and in connection with certain financial statements. Investors who purchased shares of Homology Medicines, Inc. (NASDAQ: FIXX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com